A Multidisciplinary approach to prostate cancer stem cells and therapy

Prostate cancer cells that resist treatment and spread to other organs often behave like stem cells, and researchers in Leeds are now mapping the genetic instructions that keep these dangerous cells alive. This matters because standard therapies frequently fail to eliminate the root of the tumour. The team has already separated normal and malignant prostate tissue into individual cell types, including stem cells, and found that these cancer stem cells drive tumour formation, metastasis, and therapy resistance. The current work aims to identify the specific signalling pathways and gene interactions that control stem cell survival and invasion. If successful, this research could reveal new therapeutic targets that disable the cancer stem cells directly, rather than just shrinking the bulk tumour. That would mean treatments that are less likely to fail when the cancer returns or spreads. The project is fundamental science—it does not promise an immediate new drug. But understanding how a handful of genes control stem cell behaviour in the prostate could, over time, lead to therapies that attack the disease at its most stubborn source.